Camp4 Therapeutics Corporation (CAMP)
NASDAQ: CAMP · Real-Time Price · USD
4.160
+0.180 (4.52%)
At close: Jun 3, 2026, 4:00 PM EDT
4.170
+0.010 (0.24%)
After-hours: Jun 3, 2026, 4:10 PM EDT

Camp4 Therapeutics Stock Forecast

Stock Price Forecast

According to 6 analysts polled by S&P Global, Camp4 Therapeutics stock has a consensus rating of "Buy" and an average price target of $8.20. The average 1-year stock price forecast is 97.12% higher than the current stock price, while the lowest is $5.00 (+20.19%) and the highest is $12 (+188.46%).

Price Target: $8.20 (+97.12%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$5.00$8.20$8.00$12
Change+20.19%+97.12%+92.31%+188.46%

Analyst Ratings

The average analyst rating for Camp4 Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingDec '25Jan '26Feb '26Mar '26Apr '26May '26
Strong Buy444444
Buy111111
Hold111111
Sell000000
Strong Sell000000
Total666666

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Piper Sandler
Piper Sandler
Buy
Reiterates
$12
BuyReiterates$12+188.46%May 15, 2026
Wedbush
Wedbush
Buy
Maintains
$8
BuyMaintains$8+92.31%May 8, 2026
William Blair
William Blair
Buy
Reiterates
n/a
BuyReiteratesn/an/aMay 8, 2026
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Maintains
$7
BuyMaintains$7+68.27%May 8, 2026
Rodman & Renshaw
Rodman & Renshaw
Buy
Initiates
$7
BuyInitiates$7+68.27%Apr 14, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
5.89M
from 3.50M
Increased by 68.50%
Revenue Next Year
5.28M
from 5.89M
Decreased by -10.37%
EPS This Year
-0.79
from -2.65
EPS Next Year
-0.73
from -0.79
Fiscal YearFY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
-350.00K652.00K3.50M5.89M
Revenue Growth
--86.29%436.50%68.50%
Operating Income
-45.00M-51.88M-53.09M-52.06M-57.83M
Net Income
-44.19M-49.29M-51.79M-80.40M-56.31M
EPS
-141.51-124.79-11.04-2.65-0.79
Free Cash Flow
--30.18M-26.52M-20.64M-51.00M
No. Analysts
----6

Revenue Forecast

Revenue202620272028
High9.6M
Avg5.9M
Low1,000,000

Revenue Growth

Revenue Growth202620272028
High
174.4%
Avg
68.5%
Low
-71.4%

EPS Forecast

EPS202620272028
High-0.63
Avg-0.79
Low-1.04

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Financial forecast data provided by S&P Global Market Intelligence. The data is sourced from Wall Street analysts. Data sources.